Basic dosimetry and radiobiology for radionuclide therapy (RSS3.07) - Sold out

Dr. Steffie Peters

Dr. Steffie Peters received her MSc in Biomedical Engineering in 2011 at the Eindhoven University of Technology (NL), with a focus in medical imaging. She worked as a researcher at Philips Research (NL) for several years, after which she was trained as a Medical Physics Expert at the Radboud university medical center in Nijmegen (NL). She obtained her PhD in radionuclide dosimetry in 177Lu-PSMA therapy at the Radboud University (NL) in 2022. Combining her work as a Medical Physics Expert with her research experience, she has a strong focus on dosimetry in radionuclide therapy, covering in-depth knowledge on dosimetry physics as well as coordinating dosimetry protocols and requirements in daily clinical practice. She is coordinator of the Dosimetry Core Unit, and holds a position in several international committees and projects, including the EFOMP Special Interest Group for Internal Radionuclide Dosimetry, the SAMIRA Simplerad project by the European Commission, and the EANM EARL project group for 177Lutetium quantification. 

Dr. Julie Nonnekens

Dr. Julie Nonnekens received her MSc in Biotechnology at Wageningen University (NL) in 2009. She obtained her PhD in cancer biology with the focus on DNA repair mechanisms at the University of Toulouse (FR) in 2013. Following, she was a postdoc at the Hubrecht Institute (NL) working on ribosome biogenesis in cancer and longevity.

In 2014 Julie joined the Erasmus MC Rotterdam (NL) Departments of Radiology & Nuclear Medicine and Molecular Genetics and she is now Associate Professor and leads a research group. The research of her group bridges the interests of both departments in the field of DNA damage repair mechanisms and nuclear medicine to study the radiobiology of targeted radionuclide anticancer treatment in order to ultimately optimize treatment regimens.

Julie has received several (young investigator) awards and is principal investigator on various research grants including the prestigious ERC starting grant. She is chair of the Netherlands Society of Radiobiology and co-founder of the European working group on Radiobiology of Molecular Radionuclide Therapy.